Immunoassay News and Research

RSS

Proteomics market expected to experience continual growth

The market for microarrays used to study the workings of proteins are in great demand, according to Kalorama Information. The healthcare market research publisher said "proteomics" instruments, reagents and testing are needed to discover new biomarkers and even new drugs, and that the market for them topped 5 billion dollars in 2013.

8 Jan 2015

Grand Challenges Canada announces $1.2 million in grant for 11 new global health innovations

Grand Challenges Canada, funded by the Government of Canada, today announced $1.2 million in funding for 11 new global health innovations implemented in member states of La Francophonie.

29 Nov 2014

Bio-Techne to acquire CyVek for $60M

Bio-Techne Corporation announced today that it has agreed to acquire CyVek, Inc. (CyVek) for $60 million in cash, plus a potential earn-out payment of up to $35 million based on CyVek revenue over the 30-month period following the closing and an additional potential earn-out payment based on CyVek revenue through 2020 in excess of $100 million.

4 Nov 2014

Canada funds 22 inventive ideas for improving health in low-resource countries

Grand Challenges Canada, funded by the Government of Canada, today announced $2.4 million in seed funds shared between 22 projects from Canada and nine developing nations, to pursue inventive new ideas for improving health in low-resource countries.

8 Sep 2014

SeraCare Life Sciences announces launch of new ACCURUN 501 C. difficile Control

SeraCare Life Sciences, a provider of high-quality biological materials that help optimize diagnostic performance, reliability and repeatability across the IVD lifecycle, today announced the launch of its new ACCURUN 501 C. difficile Control – the company's first molecular control product targeting hospital acquired infections.

23 Aug 2014

Bio-Techne revenue increases 16% to $92.5 million in fourth quarter 2014

Techne Corporation, (d/b/a Bio-Techne) today reported its financial results for the fourth quarter and full year ended June 30, 2014.

From ProteinSimple 11 Aug 2014

Beckman ranks among industry's highest performing Service providers in clinical diagnostics

Committed to providing the solutions labs need to meet the challenges they face, Beckman Coulter Diagnostics has been ranked among the industry's highest performing Service providers in the clinical diagnostics industry in the 2014 IMV ServiceTrak Executive Summary Report.

26 Jul 2014

Addcare’s liquid handling systems, automated immunoassay workstations, customized systems

Addcare Bio-Tech Co., Ltd. provides advanced liquid handling systems, automated immunoassay workstations and customized systems.

22 Jul 2014

Chemclin's Anti-TB assay helps in qualitative determination of Anti-TB in human serum

Chemclin's Anti-TB assay provides components for in-vitro qualitative determination of Antibody to Mycobacterium Tuberculosis (Anti-TB) in human serum or plasma by an indirect chemiluminescent assay method.

22 Jul 2014

Randox's Acusera Immunoassay Speciality 1 quality control receives FDA clearance

In Q3 of 2013, Randox announced that the Food and Drug Administration has approved the company's Acusera Immunoassay Speciality 1 quality control for use in US laboratories.

From Randox Laboratories Ltd. 22 Jul 2014

Beckman announces national availability of Prostate Health Index

Beckman Coulter Diagnostics, a global leader in prostate cancer diagnostics, announces national availability of the Prostate Health Index (phi)*, a simple, non‐invasive blood test that is three times more specific in detecting prostate cancer1 than PSA (prostate‐specific antigen).

22 Jul 2014

Novel device uses smartphone to measure cortisol concentration in saliva

Researchers have developed a device that uses any smartphone to measure the cortisol concentration in saliva. The device was presented Tuesday, June 24, at ICE/ENDO 2014, the joint meeting of the International Society of Endocrinology and the Endocrine Society in Chicago.

25 Jun 2014

Ferring Pharmaceuticals, Roche partner to make personalised infertility treatment possible

Ferring Pharmaceuticals and Roche have announced a collaboration to combine diagnostic testing technology from Roche with Ferring's human cell line derived recombinant follicle-stimulating hormone (human rFSH), a gonadotrophin currently in phase III development.

24 Jun 2014

Newborn congenital adrenal hyperplasia screening justified

The Swedish neonatal screening programme successfully detected all cases of clinically classified salt-wasting congenital adrenal hyperplasia during a 26-year period, researchers report.

5 Jun 2014

Bio-Techne makes $10M equity investment in CyVek

Techne Corporation, d/b/a Bio-Techne, announced today that it has made a $10 million equity investment in CyVek, Inc. (CyVek), with a commitment to acquire CyVek if certain future milestones are met.

4 Apr 2014

American Bio Medica's net sales decrease 7.3% in fourth quarter 2013

American Bio Medica Corporation today announced financial results for the fourth quarter and year ended December 31, 2013.

From Medica Corporation 29 Mar 2014

Singulex signs agreement to co-develop the Sgx Clarity system with Tecan

Singulex, Inc., the developer and leading provider of Single Molecule Counting (SMC) technology for clinical diagnostics and scientific discovery, today announced an agreement to co-develop the Sgx Clarity system with Tecan, a leading global provider of laboratory automation instruments.

From Tecan 25 Mar 2014

Mindray's net revenues increase 16.5% to $368.4 million in fourth quarter 2013

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2013.

From Mindray 4 Mar 2014

New biomarker for stress in wild animals facing global climate change

Chemical analyses by neuroscientist Jerrold Meyer and colleagues at the University of Massachusetts Amherst are helping to establish hair cortisol concentration (HCC) as an important new biomarker for stress in wild animals facing global climate change.

25 Jan 2014

New Access Total βhCG (5th IS) assay from Beckman Coulter receives FDA clearance and is granted CE Mark for Europe

Aligned with its commitment to help move reproductive health management forward, Beckman Coulter Diagnostics has received clearance for its new Access Total βhCG (5th IS) assay from the U.S. Food and Drug Administration (FDA) 510(k), as well as being granted the CE Mark specifically for Europe.

16 Jan 2014

Immunoassay News and Research

Proteomics market expected to experience continual growth

Grand Challenges Canada announces $1.2 million in grant for 11 new global health innovations

Bio-Techne to acquire CyVek for $60M

Canada funds 22 inventive ideas for improving health in low-resource countries

SeraCare Life Sciences announces launch of new ACCURUN 501 C. difficile Control

Bio-Techne revenue increases 16% to $92.5 million in fourth quarter 2014

Beckman ranks among industry's highest performing Service providers in clinical diagnostics

Addcare’s liquid handling systems, automated immunoassay workstations, customized systems

Chemclin's Anti-TB assay helps in qualitative determination of Anti-TB in human serum

Randox's Acusera Immunoassay Speciality 1 quality control receives FDA clearance

Beckman announces national availability of Prostate Health Index

Novel device uses smartphone to measure cortisol concentration in saliva

Ferring Pharmaceuticals, Roche partner to make personalised infertility treatment possible

Newborn congenital adrenal hyperplasia screening justified

Bio-Techne makes $10M equity investment in CyVek

American Bio Medica's net sales decrease 7.3% in fourth quarter 2013

Singulex signs agreement to co-develop the Sgx Clarity system with Tecan

Mindray's net revenues increase 16.5% to $368.4 million in fourth quarter 2013

New biomarker for stress in wild animals facing global climate change

New Access Total βhCG (5th IS) assay from Beckman Coulter receives FDA clearance and is granted CE Mark for Europe

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News